Skip to main content
Telix Pharmaceuticals Limited (ASX:TLX)
Australia flag Australia · Delayed Price · Currency is AUD
14.81
+0.25 (1.72%)
At close: Dec 5, 2025

Telix Pharmaceuticals Revenue

Telix Pharmaceuticals had revenue of $390.36M USD in the half year ending June 30, 2025, with 165.59% growth. This brings the company's revenue in the last twelve months to $664.23M, up 55.35% year-over-year. In the year 2024, Telix Pharmaceuticals had annual revenue of $484.69M with 41.49% growth.

Revenue (ttm)
$664.23M
Revenue Growth
+55.35%
P/S Ratio
4.95
Revenue / Employee
$2.84M
Employees
234
Market Cap
5.02B AUD

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024484.69M142.12M41.49%
Dec 31, 2023342.57M233.76M214.82%
Dec 31, 2022108.81M103.29M1,870.12%
Dec 31, 20215.52M1.50M37.33%
Dec 31, 20204.02M1.57M64.26%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 23.73B
Pro Medicus 212.98M
Cochlear 2.34B
Sonic Healthcare 9.65B
Ramsay Health Care 17.79B
Ansell 3.06B
Mesoblast 26.23M
Neuren Pharmaceuticals 218.86M
Revenue Rankings

Telix Pharmaceuticals News

More News